BHRB vs NKSH vs NBTB vs CARE vs JPM

For growth investors, Burke & Herbert Financial Services Corp.

(BHRB) is the stronger pick with 23. 7% revenue growth year-over-year, versus 3. 3% for JPMorgan Chase & Co. (JPM). Burke & Herbert Financial Services Corp. (BHRB) offers the better valuation at 8. 7x trailing P/E (8. 3x forward), making it the more compelling value choice. Analysts rate Burke & Herbert Financial Services Corp. (BHRB) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Burke & Herbert Financial Services Corp.

(BHRB) is the cheapest at 8. 7x versus Carter Bankshares, Inc. at 21. 3x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 5. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Burke & Herbert Financial Services Corp. wins at 0. 45x versus National Bankshares, Inc. 's 140. 16x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +118. 2%, compared to +24. 3% for National Bankshares, Inc. (NKSH). Over 10 years, the gap is even starker: JPM returned +465. 8% versus NKSH's +54. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Carter Bankshares, Inc.

(CARE) is the lower-risk stock at 0. 58β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately 64% more volatile than CARE relative to the S&P 500. On balance sheet safety, National Bankshares, Inc. (NKSH) carries a lower debt/equity ratio of 1% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Burke & Herbert Financial Services Corp.

(BHRB) is pulling ahead at 23. 7% versus 3. 3% for JPMorgan Chase & Co. (JPM). On earnings-per-share growth, the picture is similar: Burke & Herbert Financial Services Corp. grew EPS 231. 2% year-over-year, compared to 1. 5% for JPMorgan Chase & Co.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Burke & Herbert Financial Services Corp.

(BHRB) is the more profitable company, earning 23. 9% net margin versus 12. 3% for Carter Bankshares, Inc. — meaning it keeps 23. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BHRB leads at 29. 5% versus 15. 7% for CARE. At the gross margin level — before operating expenses — NBTB leads at 72. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Burke & Herbert Financial Services Corp. (BHRB) is the more undervalued stock at a PEG of 0. 45x versus National Bankshares, Inc. 's 140. 16x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Carter Bankshares, Inc. (CARE) trades at 5. 5x forward P/E versus 14. 4x for JPMorgan Chase & Co. — 8. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BHRB: 10. 3% to $74. 00.

In this comparison, NKSH (4.

2% yield), BHRB (3. 4% yield), NBTB (3. 0% yield), JPM (1. 9% yield) pay a dividend. CARE does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, JPMorgan Chase & Co.

(JPM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94), 1. 9% yield, +465. 8% 10Y return). Both have compounded well over 10 years (JPM: +465. 8%, CARE: +141. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: BHRB is a small-cap high-growth stock; NKSH is a small-cap deep-value stock; NBTB is a small-cap deep-value stock; CARE is a small-cap quality compounder stock; JPM is a large-cap deep-value stock. BHRB, NKSH, NBTB, JPM pay a dividend while CARE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.